Summary of CANTEL MEDICAL CORP

Item 5.07 Submission of Matters to a Vote of Security Holders

At the 2012 Annual Meeting of Stockholders of Cantel Medical Corp. (the "Company") held on January 11, 2013 (the "2012 Annual Meeting"), four proposals were voted on by the Company's stockholders. The proposals are described in detail in the Company's definitive proxy statement filed on November 28, 2012 (the "Proxy Statement") in connection with the 2012 Annual Meeting and summarized below.

A final voting report was produced by Broadridge Financial Solutions, Inc. ("Broadridge"), the independent inspector of elections for the 2012 Annual Meeting, certifying the following results on the four proposals:

Proposal 1   The stockholders elected all ten director nominees to serve as
             members of the Company's board of directors until the Company's 2013
             Annual Meeting of Stockholders.




                                                     Broker
Name                          For       Withheld    Non-Votes
Alan R. Batkin             22,218,705    392,660    2,349,517
Ann E. Berman              22,524,701    86,664     2,349,517
Joseph M. Cohen            20,553,429   2,057,936   2,349,517
Charles M. Diker           21,242,570   1,368,795   2,349,517
Mark N. Diker              21,249,046   1,362,319   2,349,517
George L. Fotiades         22,118,170    493,195    2,349,517
Alan J. Hirschfield        20,923,882   1,687,483   2,349,517
Andrew A. Krakauer         21,253,135   1,358,230   2,349,517
Peter J. Pronovost, M.D.   22,145,373    465,992    2,349,517
Bruce Slovin               21,228,367   1,382,998   2,349,517




Proposal 2    The stockholders approved an amendment to the Company's Certificate
              of Incorporation to increase the number of authorized shares of
              common stock from 30,000,000 to 75,000,000.




                                    Broker
   For        Against    Abstain   Non-Votes
17,094,402   7,833,392   33,088        0

Proposal 3 The stockholders approved, on an advisory basis, the compensation of the Company's Named Executive Officers.

                                  Broker
   For       Against   Abstain   Non-Votes
21,187,664   466,187   957,514   2,349,517




Proposal 4    The stockholders ratified the appointment of Ernst & Young LLP as the
              Company's Independent Registered Public Accounting Firm for the
              fiscal year ending July 31, 2013.

                                    Broker
   For        Against    Abstain   Non-Votes
23,390,490   1,562,905    7,487        0